Aixtron’s Correction Lures an Upgrade as Wall Street’s Two Titans Take Opposite Bets
Published on 07/23/2026 at 02:41 | Redaktion boerse-global.de
The selloff in Aixtron shares has become so pronounced that at least one analyst is now calling a truce. mwb research lifted its rating on the Aachen-based chip-equipment maker from “Sell” to “Hold” this week, arguing that the brutal 31% slide over the past month has largely exhausted the downside. The stock’s retreat below the €40 threshold in the prior week, the firm said, eliminated the valuation asymmetry that had previously justified a negative stance. Its price target remains pegged at €40, essentially in line with where the shares now trade.
That cautious upgrade comes as two of Wall Street’s largest investment houses move in opposite directions on their Aixtron holdings. JPMorgan Chase & Co. trimmed its voting-rights stake to 6.94% from 7.44%, according to a filing under Section 40 of the German Securities Trading Act dated July 17. The bank holds 1.96% directly in shares, with the remaining 4.99% sitting in financial instruments. Goldman Sachs Group, by contrast, increased its position to 8.60% from 8.45% as of July 16, with 3.06% in direct equity and 5.54% via derivatives. The divergence leaves Goldman as the larger of the two foreign institutional investors at Aixtron, while JPMorgan’s reduction keeps it below the 7.5% threshold.
Such threshold notifications have become routine at Aixtron in recent weeks, as investment banks regularly adjust positions tied to trading and hedging activities. The filings themselves offer no window into whether the moves reflect genuine conviction about the company or are simply the byproduct of client flows and derivative hedging strategies. What is clear is that both institutions are predominantly using structured instruments rather than outright share purchases, suggesting tactical positioning rather than a strategic reallocation.
Should investors sell immediately? Or is it worth buying Aixtron?
The stock itself is showing tentative signs of stabilization after a punishing stretch. Aixtron closed Wednesday at €41.60, down 1.33% on the day, but the modest decline felt almost like a breather after the prior weeks’ rout. The 30-day drop stands at 25.07%, a sharp comedown from the 52-week high of €62.68 reached in mid-June. That peak now sits 33.63% above the current price. Yet the longer-term picture remains striking: the shares have still more than tripled over the past twelve months, and the year-to-date gain stands at 140.86%.
The technical backdrop offers mixed signals. The relative strength index has recovered to 40.2, a neutral reading that suggests the oversold conditions of recent days have begun to ease. On Tuesday, the stock briefly spiked more than 8% in a single session before giving back some of those gains. The annualized 30-day volatility, however, remains elevated at 80.11%, underscoring that the semiconductor sector continues to trade as a high-beta speculation zone where sharp swings are the norm.
Analyst opinions on fair value remain deeply fractured. Barclays sees the current level as roughly appropriate with a €39 target. JPMorgan, despite trimming its own stake, maintains an “Overweight” rating with a €70 price target, citing rising demand for MOCVD systems used in AI applications. The nearly €30 gap between the two extremes illustrates just how wide the range of outcomes is for a company riding the AI-optoelectronics and gallium-nitride wave.
The next major catalyst arrives on July 30, when Aixtron is scheduled to report its half-year results. mwb research expects order intake to exceed €200 million for the second quarter. The critical question will be how quickly the company can convert its backlog into revenue — and whether the recent correction has been a healthy consolidation or the beginning of a deeper reassessment. For now, the market capitalization sits at €4.45 billion, with institutional behavior and share-price momentum pointing in different directions.
Ad
Aixtron Stock: New Analysis - 23 July
Fresh Aixtron information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
